124 related articles for article (PubMed ID: 11805135)
1. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.
Howard LM; Ostrovidov S; Smith CE; Dal Canto MC; Miller SD
J Clin Invest; 2002 Jan; 109(2):233-41. PubMed ID: 11805135
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
Howard LM; Miga AJ; Vanderlugt CL; Dal Canto MC; Laman JD; Noelle RJ; Miller SD
J Clin Invest; 1999 Jan; 103(2):281-90. PubMed ID: 9916140
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ.
Howard LM; Miller SD
J Immunol; 2001 Feb; 166(3):1547-53. PubMed ID: 11160195
[TBL] [Abstract][Full Text] [Related]
4. FcR interactions do not play a major role in inhibition of experimental autoimmune encephalomyelitis by anti-CD154 monoclonal antibodies.
Nagelkerken L; Haspels I; van Rijs W; Blauw B; Ferrant JL; Hess DM; Garber EA; Taylor FR; Burkly LC
J Immunol; 2004 Jul; 173(2):993-9. PubMed ID: 15240687
[TBL] [Abstract][Full Text] [Related]
5. Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses.
Howard LM; Dal Canto MC; Miller SD
J Neuroimmunol; 2002 Aug; 129(1-2):58-65. PubMed ID: 12161021
[TBL] [Abstract][Full Text] [Related]
6. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide.
Laman JD; Maassen CB; Schellekens MM; Visser L; Kap M; de Jong E; van Puijenbroek M; van Stipdonk MJ; van Meurs M; Schwärzler C; Günthert U
Mult Scler; 1998 Jun; 4(3):147-53. PubMed ID: 9762665
[TBL] [Abstract][Full Text] [Related]
7. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD
J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
9. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
[TBL] [Abstract][Full Text] [Related]
10. Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood.
Hofstetter HH; Kovalovsky A; Shive CL; Lehmann PV; Forsthuber TG
J Neuroimmunol; 2007 Jul; 187(1-2):20-30. PubMed ID: 17482277
[TBL] [Abstract][Full Text] [Related]
11. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
[TBL] [Abstract][Full Text] [Related]
12. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
[TBL] [Abstract][Full Text] [Related]
13. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation.
Ruiz PJ; Garren H; Ruiz IU; Hirschberg DL; Nguyen LV; Karpuj MV; Cooper MT; Mitchell DJ; Fathman CG; Steinman L
J Immunol; 1999 Mar; 162(6):3336-41. PubMed ID: 10092787
[TBL] [Abstract][Full Text] [Related]
14. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
Sobel RA; Kuchroo VK
J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of immunotherapeutic intervention by anti-CD154 (CD40L) antibody in high-risk corneal transplantation.
Qian Y; Hamrah P; Boisgerault F; Yamagami S; Vora S; Benichou G; Dana MR
J Interferon Cytokine Res; 2002 Dec; 22(12):1217-25. PubMed ID: 12581495
[TBL] [Abstract][Full Text] [Related]
16. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation.
Katsara M; Deraos S; Tselios TV; Pietersz G; Matsoukas J; Apostolopoulos V
Immunotherapy; 2014; 6(6):709-24. PubMed ID: 25186603
[TBL] [Abstract][Full Text] [Related]
17. Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis.
Luca ME; Kel JM; van Rijs W; Wouter Drijfhout J; Koning F; Nagelkerken L
J Neuroimmunol; 2005 Mar; 160(1-2):178-87. PubMed ID: 15710471
[TBL] [Abstract][Full Text] [Related]
18. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
Cua DJ; Coffman RL; Stohlman SA
J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
[TBL] [Abstract][Full Text] [Related]
19. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells.
Aloisi F; Penna G; Polazzi E; Minghetti L; Adorini L
J Immunol; 1999 Feb; 162(3):1384-91. PubMed ID: 9973393
[TBL] [Abstract][Full Text] [Related]
20. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
